Blood

ISSN: 0006-4971

Journal Home

Journal Guideline

Blood Q1 Unclaimed

American Society of Hematology United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Blood, the official journal of the American Society of Hematology, published online and in print, provides an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology. Acceptance of manuscripts is based on the originality and importance of the observations or investigations, the quality of the work and validity of the evidence, the clarity of presentation, and the relevance to our readership and field. All articles are expected to be concise, well organized and clearly written.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Price

3170 €

Gold OA

-

Green OA

910 €

Non OA

Metrics

Blood

5,416

SJR Impact factor

448

H Index

852

Total Docs (Last Year)

3077

Total Docs (3 years)

26808

Total Refs

23671

Total Cites (3 years)

2168

Citable Docs (3 years)

10,56

Cites/Doc (2 years)

31,46

Ref/Doc


Best articles

A genome-wide meta-analysis of nodular sclerosing Hodgkin lymphoma identifies risk loci at 6p21.32

View more

A phase 1 multidose study of SGN-30 immunotherapy in patients with refractory or recurrent CD30+ hematologic malignancies

View more

A Phase 1b Study Investigating the Combination of the Tetravalent Bispecific NK Cell Engager AFM13 and Pembrolizumab in Patients with Relapsed/Refractory Hodgkin Lymphoma after Brentuximab Vedotin Failure: Updated Safety and Efficacy Data

View more

A Phase III Study for the Treatment of Children and Adolescents with Newly Diagnosed Low Risk Hodgkin Lymphoma (HL)

View more

A specific role of integrin Mac-1 in accelerated macrophage efflux to the lymphatics

View more

A switch in infected erythrocyte deformability at the maturation and blood circulation of Plasmodium falciparum transmission stages

View more

Advanced Stage Classical Hodgkin Lymphoma Patients with a Negative PET-Scan Following Treatment with ABVD Have Excellent Outcomes without the Need for Consolidative Radiotherapy Regardless of Disease Bulk at Presentation

View more

AHOD0031: A Phase III Study of Dose-Intensive Therapy for Intermediate Risk Hodgkin Lymphoma: A Report From the Children's Oncology Group

View more

Allogeneic hematopoietic stem cell transplantation in children and adolescents with recurrent and refractory Hodgkin lymphoma: an analysis of the European Group for Blood and Marrow Transplantation

View more

Allogeneic Stem Cell Transplantation from Unrelated Donors after Reduced Intensity Conditioning in Patients with MDS/sAML. A Report from the Chronic Leukemia Working Party (CLWP) of the EBMT.

View more

Atypical prediagnosis Epstein-Barr virus serology restricted to EBV-positive Hodgkin lymphoma

View more

Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trial

View more
SHOW MORE ARTICLES

BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patients

View more

Bleeding in patients receiving vitamin K antagonists who would have been excluded from trials on which the indication for anticoagulation was based

View more

Brentuximab Vedotin Improves HCT-CI, CR Status, and Peri-Transplant Toxicity In Patients With Relapsed/Refractory Hodgkin Lymphoma Heading To RIC Allo-HCT

View more

Brentuximab Vedotin Plus ESHAP (BRESHAP) Is a Highly Effective Combination for Inducing Remission in Refractory and Relapsed Hodgkin Lymphoma Patients Prior to Autologous Stem Cell Transplant: A Trial of the Spanish Group of Lymphoma and Bone Marrow

View more

Busulfan bioavailability

View more

Chloroquine treatment affects T-cell priming to minor histocompatibility antigens and graft-versus-host disease

View more

Chromosomal rearrangements involving the BCL3 locus are recurrent in classical Hodgkin and peripheral T-cell lymphoma

View more

Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients

View more

Circulating clonotypic B cells in classic Hodgkin lymphoma

View more

Clonotypic B cells in classic Hodgkin lymphoma

View more

CNS Hodgkin lymphoma

View more

Continuous release of secretory granule proteoglycans from a cell strain derived from the bone marrow of a patient with diffuse cutaneous mastocytosis

View more

Comments

No comments ... Be the first to comment!